Literature DB >> 1095996

Postmenopausal symptomatology, maturation index, and plasma estrogen levels.

S C Stone, A Mickal, P H Rye.   

Abstract

An attempt to correlate postmenopausal symptoms with the vaginal maturation index and plasma levels of estrogen was made in a group of patients with surgical menopause. The group was followed up monthly for 6 months in a double-blind study during which the patients received equine esterified estrogen and synthetic esterfield estrogens. No statistical difference in plasma levels of estrogen was found between the group of patients with symptoms and the patients without symptoms, with or without estrogen therapy. There was no correlation of the maturation index with the presence or absence of symptoms or with the estrogen plasma levels.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095996     DOI: 10.1097/00006250-197506000-00005

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?

Authors:  Kathleen M Kokolus; Chi-Chen Hong; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

2.  Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial.

Authors:  Ellen B Gold; John P Pierce; Loki Natarajan; Marcia L Stefanick; Gail A Laughlin; Bette J Caan; Shirley W Flatt; Jennifer A Emond; Nazmus Saquib; Lisa Madlensky; Sheila Kealey; Linda Wasserman; Cynthia A Thomson; Cheryl L Rock; Barbara A Parker; Njeri Karanja; Vicky Jones; Richard A Hajek; Minya Pu; Joanne E Mortimer
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

3.  Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors.

Authors:  Alison J Huang; Elya E Moore; Edward J Boyko; Delia Scholes; Feng Lin; Eric Vittinghoff; Stephan D Fihn
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

Review 4.  Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy.

Authors:  Santiago Palacios; María Jesús Cancelo
Journal:  Int J Womens Health       Date:  2016-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.